• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Soleo Health partners for RYPLAZIM® treatment.

    06 May 2024 //

    BUSINESSWIRE

    Kedrion Announces Rare Disease Medicine RYPLAZIM® Now Available in US

    29 Apr 2024 //

    PR NEWSWIRE

    Liminal BioSciences Announces Upcoming Presentations for Ryplazim®

    04 Nov 2020 //

    PRNEWSWIRE

    Liminal BioSciences Provides Update on Progress on BLA for Ryplazim®

    21 Sep 2020 //

    PRNEWSWIRE

    Liminal resubmits Biologics License Application to U.S. FDA for Ryplazim

    08 Sep 2020 //

    PRNEWSWIRE

    Prometic presents new PBI-4050 and Ryplazim™ (plasminogen) data on lung fibrosis

    22 May 2019 //

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.